|Day's Range||56.35 - 57.27|
|52 Week Range||46.01 - 77.12|
|PE Ratio (TTM)||19.77|
|Dividend & Yield||1.56 (2.75%)|
|1y Target Est||N/A|
The FDA has approved its first commercial medicine, and because it could reshape a big indication, the company may have just gotten a lot more interesting to suitors.
Jim Cramer discusses not discussing the 'market' and also suggests a Darth Vader-Amazon meeting.
Bristol-Myers reported a net profit of ~$1.57 billion in 1Q17—compared to $1.19 billion in 1Q16. Analysts expect a net profit of $1.18 billion during 2Q16.